Pfizer’s Commitment to the Advance Market Commitment (AMC)

Slides:



Advertisements
Similar presentations
Target Product Profile and technical requirements Pre-tender Meeting Pneumococcal Vaccines under the AMC Unicef Supply Division, Copenhagen 26 August.
Advertisements

XIII Meeting of the Authorities and Executive Committee of the CIE Patricia Quiroz, Specialist Office of Education and Culture September 6, 2012 Executive.
EPI in development: HepB/Hib combination vaccine tender overview Pre-tender meeting UNICEF Supply Division, December 2008 Meredith Shirey.
AMRO Bolivia (2008) Guyana (2010) Haiti (2013) Honduras(2009) Nicaragua (2006) GAVI-supported RV introductions by WHO region: 18 countries * AFRO AngolaKenya.
National RV introductions by WHO region: 69 countries* AMRO Bolivia Brazil Cayman Islands ** Colombia Dominican Republic Ecuador El Salvador Guatemala.
Why Not the Best? A High Performance Health System in Hawaii Hawaii Uninsured Project Fall Forum October 23, 2006 Anne Gauthier Senior Policy Director.
Critical conversations in Public-private partnerships Dr Ranjana Kumar 1 st November 2007.
Procurement of Pneumococcal Vaccines under the Advance Market Commitment Pre Tender Meeting UNICEF Supply Division, 10-11th December 2008 Ann Ottosen.
Advance Market Commitments for Vaccines Carlo Monticelli International Financial Relations Ministero dell’Economia e delle Finanze.
London November 9th1 The Independent Assessment Committee London November 9th, 2006.
Update on Vaccines not Included in this Tender: Rotavirus Vaccines Pre Tender Meeting UNICEF Supply Division, 10-11th December 2008 Ann Ottosen.
Julian Lob-Levyt Health Systems Funding Platform update ECOSOC Coordination Segment United Nations Headquarters, 6 July 2010.
Maternal, neonatal, child health and nutrition
VISION 2020 LATIN AMERICA STRATEGIC PLAN Planning process and March 2012 meeting in Lima, Peru sponsored by: ORBIS, CBM, and UNESCO ORBIS CBM UNESCO.
Pre Tender Meeting UNICEF Supply Division, December 2008 Rob Matthews UNICEF Vaccine Procurement for Developing Countries.
The Pneumococcus Challenge
Yogan Pillay National Department of Health, South Africa July 24, 2014
International Food Aid and Development Conference August 2, 2010 M. Ann Tutwiler Global Food Security Coordinator Office of the Secretary, USDA.
Manila, Philippines 21 October 2011 Regional review: Challenges faced by the Asia-Pacific countries International Conference on MDGS Progress towards the.
OIC-SHPA & Vaccines Need Assessment in OIC Member Countries
Goal 4: Reduce Child Mortality Target: Reduce by two thirds, between 1990 and 2015, the under five mortality rate.
Integrating Rural Household Surveys November, 2004 Fred Vogel The World Bank.
ANNUAL REPORT 2010 HIGHLIGHTS. It’s a record! The international donor community rallied behind the goals of UNFPA, contributing a record $850 million.
The Renewable Energy and Energy Efficiency Partnership (REEEP) Inter- Parliamentary Meeting on Renewable Energy and Energy Efficiency October
Sources of Support and What They Mean to the Field Dr. Duff Gillespie June 15 th, 2002 Africa SOTA, Nairobi.
International Finance Facility for Immunisation Anna Guthrie International Poverty Reduction Team.
Meningitis Vaccine Procurement. Meningitis belt countries in Africa.
Education For All Fast Track Initiative Rosemary Bellew Manager, FTI Secretariat.
Infrastructure Consortium Meeting June IFF for Immunziation Andrew Jones Senior Programme Officer, Innovative Financing.
The Accelerated Data Program ( ADP ) The International Household Survey Network ( IHSN ) PARIS21 Steering Committee Paris, 6 June 2008.
Countdown to 2015: Tracking Progress in Child Survival. London, December Thinking Big: Going into Action for Child Survival Sustainable Financing.
MEDICAL INNOVATION March What Are The Public Health Benefits of Medical Innovation? Breakthrough medicines New devices Innovative medical procedures.
Polio Eradication  Although the number of endemic countries is at an all-time low in 2002, the actual number of cases was approximately four times higher.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
DRAFT V1 National Vaccine Supply Chain Innovations: Country Commitment to Ownership, Sustainability & Impact GAVI Partners’ Forum WHO – UNICEF – GAVI -
AMC Governance and Institutional Support. Objectives Build on existing capacity Ensure appropriate independence and credibility through transparency,
MILLENIUM DEVELOPMENT GOALS Board review Notes Dr. Theresita R. Lariosa.
Americas Bolivia (2008) Guyana (2010) Haiti (2013) Honduras (2009) Nicaragua (2006) Europe Armenia (2012) Georgia (2013) Moldova (2012) Middle East Tajikistan.
UNESCO INSTITUTE for STATISTICS UNESCO Institute for Statistics: Statistical Capacity Building.
MAIN ISSUES FOR 62 nd EXCOM MEETING Joint Meeting of the Latin American and Caribbean Networks of Ozone Officers Mexico City, Mexico, 6 -8 October 2010.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.
A Vaccine Supply Update For The U.S. Market A Presentation At National Advisory Committee Meeting February 4, 2003 Dean Mason Chief, Program Support Branch.
Building the Partnership for Sustainable Energy Budapest, September 30 th 2004 REEEP - renewable energy & energy efficiency partnership Dr. Marianne Osterkorn.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Can we achieve rotavirus vaccine immunization worldwide by 202X? Global Vaccines 202X: Access, Equity, Ethics May 3, 2011.
The Pilot Advance Market Commitment for Vaccines Tania Cernuschi Senior Manager, AMC GAVI Alliance Marketplace on Innovative.
This vaccine webinar series is provided as a community service by Homefirst Natural Pharm Source
Unicef began its mission in 1946 as a relief organization for children after World War II. Introduction.
Pneumococcal Vaccine Use Around the World: Successes and Challenges Adam L. Cohen, MD MPH Respiratory Diseases Branch, Division of Bacterial Diseases Centers.
Mandy Metzcher HSC 4624 Instructor: Bobbie Konter Spring 2012 The Importance of Millennium Development Goal 4 and the Health of Children.
BASIC FACTS ABOUT GAVI, THE VACCINE ALLIANCE Page: 1 #vaccineswork Gavi/2012/Doune Porter.
The Great Exposé on Global Vaccination Strategies Kris Gaublomme, MD February 11, 2009.
Vaccine Development, Innovations and Investments Oslo Malaria Conference, “Getting To Zero” Jean Stéphenne, Chairman and President GlaxoSmithKline Biologicals.
York, North Yorkshire & East Riding Local Enterprise Partnership Bio-economy Growth Fund Application process September 2016.
AFRICAN RENAISSANCE AND INTERNATIONAL CO-OPERATION FUND ANNUAL REPORT 2015/16 Presentation to Portfolio Committee on International Relations and Cooperation.
Global Overview of Measles
Innovative Financing Mechanisms
Vaccine Preventable Diseases:
Charts included in the Progress Report on MDGs
Pneumococcal Vaccine AVI version 0.1
POLIOPLUS FACT SHEET Feb 2018
The Polio Eradication and Endgame Strategic Plan
Progress and Challenges with achieving Universal Immunization Coverage
Another Great Leap Forward
Think Locally, Act Globally
Pre-tender Meeting Pneumococcal Vaccines under the AMC
Global Health Exchange Conference, Dublin – 6 November 2018
Building a secure Home Affairs
The Multilateral Debt Relief Initiative
Presentation transcript:

Pfizer’s Commitment to the Advance Market Commitment (AMC)

Pfizer Committed to Reducing Childhood Mortality (MDG 4) Partnership with UNICEF, the GAVI Alliance and the governments of Rwanda and The Gambia to donate more than 3 million doses of Prevenar* for the period Both countries will transition to the AMC this year Leading the fight against PD in China where one in every four children is a carrier of the bacteria – Jointly, with the Chinese Medical Association and the China Preventative Medicine Association, developed and sponsored the launch of “Guidelines on Control Techniques of Children’s Pneumococcal Disease” 2008 economic analysis of infant inoculation with Prevenar in Latin America and the Caribbean estimated that the introduction of the vaccine had the potential to reduce childhood mortality and be highly cost effective 2010 Poland Study on the use of Prevenar shows significant fall in the average pneumonia admission rates Source: Innovative Partnerships – Progress Toward Achieving the Millennium Development Goals - Pfizer *Trademark

Faster Access for Developing Countries GAVI and the Advance Market Commitment (AMC) Program AMC supply agreement announced March countries are approved by GAVI for AMC program WHO granted prequalification for Prevenar 13* Single Dose Vial (SDV) August 2010 AMC Independent Assessment Committee approved Prevenar 13 as eligible for purchase August 2010 First shipment to UNICEF through AMC executed on 29 October 2010 Yemen, Sierra Leone, Nicaragua, Honduras, Guyana, Mali and DR Congo initiated NIP programs with Prevenar 13 via the AMC Prevnar 13 is not approved for the prevention of pneumonia caused by vaccine serotypes in the United States. *Trademark

Pfizer’s Commitments to the AMC Deliver ~30 million doses of Prevenar 13* annually beginning 2013 Vaccine production plan (capacity expansion plan) –Capital investments –Process improvements –Efficiency measures across supply network Develop a preserved multi-dose vial specifically for AMC –4-dose vial – subject to prequalification requirements –Support countries with difficult infrastructures Doses (millions) Pfizer GSK *Trademark